Experience (Mostly Negative) with the Use of Sympathomimetic Agents for Weight Loss

Sympathomimetic agents have a poor history of long-term success in the treatment of obesity. From earlier experiences with amphetamine and its analogs, to more recent drugs with direct effects on adrenergic receptors or indirect effects from release of catecholamines or inhibition of reuptake, cardi...

Full description

Saved in:
Bibliographic Details
Main Author: Mario A. Inchiosa (Author)
Format: Book
Published: Hindawi Limited, 2011-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a868c2364d14be4b90873467b00253c
042 |a dc 
100 1 0 |a Mario A. Inchiosa  |e author 
245 0 0 |a Experience (Mostly Negative) with the Use of Sympathomimetic Agents for Weight Loss 
260 |b Hindawi Limited,   |c 2011-01-01T00:00:00Z. 
500 |a 2090-0708 
500 |a 2090-0716 
500 |a 10.1155/2011/764584 
520 |a Sympathomimetic agents have a poor history of long-term success in the treatment of obesity. From earlier experiences with amphetamine and its analogs, to more recent drugs with direct effects on adrenergic receptors or indirect effects from release of catecholamines or inhibition of reuptake, cardiovascular toxicity (strokes and cardiac arrhythmias) has been the major concern. These concerns also extended to food supplements containing ephedra alkaloids and may require consideration for current supplements containing the sympathomimetic drug, synephrine. 
546 |a EN 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Journal of Obesity, Vol 2011 (2011) 
787 0 |n http://dx.doi.org/10.1155/2011/764584 
787 0 |n https://doaj.org/toc/2090-0708 
787 0 |n https://doaj.org/toc/2090-0716 
856 4 1 |u https://doaj.org/article/9a868c2364d14be4b90873467b00253c  |z Connect to this object online.